Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Bruinsma, NienkeKristinsson, Karl G
Bronzwaer, Stef
Schrijnemakers, Paul
Degener, John
Tiemersma, Edine
Hryniewicz, Waleria
Monen, Jos
Grundmann, Hajo
Issue Date
2004
Metadata
Show full item recordCitation
J. Antimicrob. Chemother. 2004, 54(6):1045-50Abstract
OBJECTIVES: To forecast trends in resistance to penicillin and erythromycin among Streptococcus pneumoniae in Europe. METHODS: Since 1999, the European Antimicrobial Resistance Surveillance System (EARSS) has collected routine antimicrobial susceptibility test results of S. pneumoniae. To observe and predict changes of reduced susceptibility over time, we used a multinomial logistic regression model. RESULTS: Large variations in penicillin and erythromycin non-susceptibility were observed between countries, and reduced susceptibility to erythromycin (17%) has become more frequent than reduced susceptibility to penicillin (10%) in Europe overall. An overall decrease in single penicillin non-susceptibility, but an increase in dual non-susceptibility was observed, indicating a shift of single penicillin to combined non-susceptibility with erythromycin. By 2006, the proportion of single erythromycin and dual non-susceptibility could increase to as much as 20.4% and 8.9%, respectively. CONCLUSIONS: Our results indicate that appropriately dosed beta-lactams for empirical therapy are still the treatment of choice, and that macrolides should be used with prudence.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAdditional Links
http://jac.oxfordjournals.org/cgi/content/abstract/54/6/1045ae974a485f413a2113503eed53cd6c53
10.1093/jac/dkh458
Scopus Count
Collections
Related articles
- Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
- Authors: Fenoll A, Aguilar L, Granizo JJ, Giménez MJ, Aragoneses-Fenoll L, Mendez C, Tarragó D
- Issue date: 2008 Dec
- Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland.
- Authors: Clarke P, Murchan S, Smyth EG, Humphreys H
- Issue date: 2004 Jul
- Increase of resistance to macrolides in invasive Streptococcus pneumoniae in Spain (2000-2001).
- Authors: Oteo J, Campos J, Cruchaga S, Baquero G, Lázaro E, Madurga M, de Abajo FJ, Baquero F, Spanish EARSS Group.
- Issue date: 2004 Sep
- Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region.
- Authors: Borg MA, Tiemersma E, Scicluna E, van de Sande-Bruinsma N, de Kraker M, Monen J, Grundmann H, ARMed Project members and collaborators.
- Issue date: 2009 Mar
- Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
- Authors: Flamaing J, Verhaegen J, Vandeven J, Verbiest N, Peetermans WE
- Issue date: 2008 Jan